Cargando…

Lung adenocarcinoma-related target gene prediction and drug repositioning

Lung cancer is the leading cause of cancer deaths globally, and lung adenocarcinoma (LUAD) is the most common type of lung cancer. Gene dysregulation plays an essential role in the development of LUAD. Drug repositioning based on associations between drug target genes and LUAD target genes are usefu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Rui Xuan, Siriwanna, Damrongrat, Cho, William C., Wan, Tsz Kin, Du, Yan Rong, Bennett, Adam N., He, Qian Echo, Liu, Jun Dong, Huang, Xiao Tai, Chan, Kei Hang Katie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445420/ https://www.ncbi.nlm.nih.gov/pubmed/36081949 http://dx.doi.org/10.3389/fphar.2022.936758

Ejemplares similares

Drug repositioning for esophageal squamous cell carcinoma
por: Bennett, Adam N., et al.
Publicado: (2022)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Enhancing the Promise of Drug Repositioning through Genetics
por: Pritchard, Jayne-Louise E., et al.
Publicado: (2017)

Lead Optimization of Dehydroemetine for Repositioned Use in Malaria
por: Panwar, Priyanka, et al.
Publicado: (2020)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

Blood Immune Cell Composition Associated with Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis
por: Liu, Jia-Chen, et al.
Publicado: (2021)

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis
por: Liu, Jia-Chen, et al.
Publicado: (2022)

Identifying Predictors of COVID-19 Mortality Using Machine Learning
por: Wan, Tsz-Kin, et al.
Publicado: (2022)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
por: Zhu, Liyuan, et al.
Publicado: (2020)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
por: Mucke, Hermann A. M.
Publicado: (2017)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
por: Mejía-Pedroza, Raúl A., et al.
Publicado: (2018)

Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
por: Sestili, Piero, et al.
Publicado: (2020)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021)

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity
por: Wakai, Eri, et al.
Publicado: (2022)

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022)

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
por: Zhang, Yuchen, et al.
Publicado: (2022)

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
por: Chen, Yu-An, et al.
Publicado: (2018)

Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018)

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020)

Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
por: Peña-Corona, Sheila I., et al.
Publicado: (2023)

Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics
por: Chu, Liang-Hui, et al.
Publicado: (2015)

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
por: Zhu, Yanlin, et al.
Publicado: (2020)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022)

A Mendelian randomization-based exploration of red blood cell distribution width and mean corpuscular volume with risk of hemorrhagic strokes
por: Liu, Jundong, et al.
Publicado: (2022)

Canary: an automated tool for the conversion of MaCH imputed dosage files to PLINK files
por: Bennett, Adam N., et al.
Publicado: (2022)

Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review
por: Chan, Vivien Kin Yi, et al.
Publicado: (2022)

Regulatory Master Genes Identification and Drug Repositioning by Integrative mRNA-miRNA Network Analysis for Acute Type A Aortic Dissection
por: Fang, Junjun, et al.
Publicado: (2021)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
por: Shao, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5nmcpodju7hm121m4s6stbgbvv